Research Guides
Long-form research guides on peptide reconstitution, dosing protocols, sourcing and compound comparisons, written for laboratory research use.
All Guides
7 guidesKLOW Peptide Blend: Complete Research Guide to KPV, GHK-Cu, BPC-157 and TB-500
KLOW is a four-peptide research blend containing KPV (Lys-Pro-Val), GHK-Cu (glycyl-L-histidyl-L-lysine copper complex), BPC-157 (Body Protection Compound-157) and TB-500 (synthetic Thymosin β-4). It is the four-component evolution of the three-peptide GLOW stack, and the addition is KPV. Each component acts on a different part of the tissue-repair cascade — NF-κB inflammatory signalling, extracellular matrix remodelling, local VEGF-mediated angiogenesis, and systemic actin-mediated cell migration respectively. All material is supplied for in-vitro laboratory research use only.
Updated
Research GuideGLOW vs KLOW Peptide Blend: Composition, Mechanisms and Research Differences
GLOW and KLOW are the same regenerative research formulation with one difference: KLOW contains KPV. GLOW is a three-peptide blend of GHK-Cu, BPC-157 and TB-500. KLOW is those same three peptides plus KPV (Lys-Pro-Val, C16H30N4O4, 342.4 Da, CAS 67727-97-3), the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone, which contributes NF-κB-directed anti-inflammatory activity and gut-barrier research relevance. No published study has compared the two formulations head to head, so the incremental contribution of KPV is inferred from single-compound literature rather than measured directly.
Updated
Research GuideKLOW Peptide Research Protocol: 80mg Vial Reconstitution and Concentration Guide
An 80 mg KLOW vial reconstituted with 2.5 mL of bacteriostatic water gives 32 mg/mL of total blend mass. The governing relationship is arithmetic, not a protocol: concentration (mg/mL) equals peptide mass (mg) divided by diluent volume (mL). At 2 mL that is 40 mg/mL, at 3 mL 26.67 mg/mL, at 4 mL 20 mg/mL — every figure expressed as total blend mass, never as the concentration of any single peptide. Per-component concentration requires the compositional ratio printed on the batch Certificate of Analysis. This page is solution-preparation guidance for in-vitro laboratory work. It contains no dosing schedule, no administration route and no frequency chart, because no pharmacokinetic study of KLOW as a four-peptide blend has been published and the material is not supplied for use in any living subject.
Updated
Research GuideBPC-157 + TB-500 Wolverine Stack: Complementary Mechanisms in Tissue Repair Research
BPC-157 and TB-500 act at different points of the tissue-repair cascade, which is why they are studied together rather than treated as interchangeable. BPC-157 (15 residues, GEPPPGKPADDAGLV, C62H98N16O22, 1,419.5 Da, CAS 137525-51-0) upregulates VEGF and activates focal adhesion kinase and paxillin where it is introduced. TB-500 (synthetic Thymosin β-4, C212H350N56O78S, 4,963.4 Da, CAS 77591-33-4, carrying the LKKTET actin-binding motif at residues 17–22) sequesters monomeric G-actin, releasing the cytoskeletal brake on cell migration. That sequential reading is a mechanistic inference drawn from two separate single-compound literatures — no published study has run the two compounds together and measured the result, and both are supplied for in-vitro laboratory research only.
Updated
Research GuideGHK-Cu Copper Peptide: Research Guide to Collagen Synthesis, Tissue Remodeling and Anti-Aging Studies
GHK-Cu is glycyl-L-histidyl-L-lysine coordinated with a copper(II) ion — molecular formula C14H24CuN6O4, molecular weight 403.9 Da as the copper complex against 340.4 Da for the free tripeptide. In cell-culture models it signals dermal fibroblasts to upregulate collagen transcription through direct effects on collagen gene expression while simultaneously activating matrix metalloproteinases 1 and 2, so the net effect studied is matrix turnover rather than matrix accumulation. A second, mechanistically separate arm is proposed to deliver bioavailable copper to lysyl oxidase, the enzyme that crosslinks collagen and elastin fibrils. GHK-Cu is not FDA-approved for human therapeutic use and is supplied for in-vitro laboratory research only.
Updated
Research GuideTesamorelin Research Guide: GHRH Analog Mechanism, IGF-1 Signaling and Laboratory Protocols
Tesamorelin is a stabilized 44-residue analog of growth hormone-releasing hormone — C221H366N72O67S, 5,135.9 Da, CAS 218949-48-5 — carrying a trans-3-hexenoyl cap at the N-terminus that blocks the dipeptidyl peptidase IV cleavage which destroys native GHRH within minutes. It binds GHRH-R on anterior pituitary somatotrophs, driving pulsatile endogenous growth hormone release that leaves hypothalamic somatostatin feedback intact, which exogenous HGH does not. Downstream, GH drives hepatic IGF-1 production and raises lipolytic tone, with selectivity for visceral over subcutaneous adipose depots reported in the trial program and not yet mechanistically explained. Tesamorelin is the rare research-catalog compound holding a current FDA approval — as the drug product EGRIFTA SV, for one indication in one patient population. That approval covers the manufactured pharmaceutical. It does not extend to research-market material, which is supplied for in-vitro laboratory research only.
Updated
Research GuideResearch Peptides USA: A Sourcing Guide to HPLC-Verified Laboratory-Grade Compounds
Evaluating a research peptide supplier comes down to four documents and one question each. HPLC purity tells you what proportion of the material is the target peptide by area under the curve — it does not tell you what the remainder is. LC-MS/MS tells you the molecular identity, which is the only reliable way to know that the powder in the vial is the molecule on the label. LAL endotoxin testing measures bacterial endotoxin load, not sterility. And a batch-specific Certificate of Analysis ties all three to the lot number printed on the vial, which is what makes a result reproducible. Most compounds sold on this market are not FDA-approved for human use, several are WADA-prohibited, and research-market material is not manufactured under pharmaceutical GMP.
Updated
Continue Researching
How to Reconstitute Peptides
Bacteriostatic water protocol, from diluent volume to vial labelling.
Research Library
Scientific articles and analysis across the full compound range.
Compound Reference Library
Per-compound reference pages grouped by research area.
Lab Results & CoAs
Third-party HPLC purity data and Certificates of Analysis.